Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP): A Phase Ib/II Open-Label Trial

NCT07477418 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT07477418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07477418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP): A Phase Ib/II Open-Label Trial
Lead sponsor
University of Vermont
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
December 31, 2031
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable pancreatic cancer, pancreatic ductal adenocarcinoma (pdac), pancreatic neoplasms